APPLICATION
ANDA075578
TYPE
ANDA
ORIGINAL APPROVAL
2000-08-22
LATEST ACTION
2015-04-14
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
ENALAPRILATPrescription
ENALAPRILAT 1.25MG/ML · INJECTABLE · INJECTION
Approval history
2015-04-14Labeling · Supplement 17AP
2010-04-27Labeling · Supplement 7AP
2004-01-02Labeling · Supplement 3AP
2002-12-19Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.